Dow Inc. Class Action Lawsuit
Analysis based on 8 articles · First reported Aug 29, 2025 · Last updated Oct 11, 2025
The market is negatively impacted by the class action lawsuit against Dow Chemical Company, as it highlights potential financial misrepresentation and poor performance. Dow Chemical Company's stock price experienced significant declines following the downgrade, disappointing earnings, and dividend cut, signaling investor concern about its future profitability and stability.
Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Dow Chemical Company, DowDuPont — Dow Chemical Company, and certain executives, including CEO Jim Fitterling. The lawsuit alleges that Dow Chemical Company made false and misleading statements to investors between January 30, 2025, and July 23, 2025, regarding its ability to mitigate macroeconomic and tariff-related headwinds, and understated the negative impacts on its business. Key events cited include Bank of Montreal — BMO Capital Markets downgrading Dow Chemical Company's stock on June 23, 2025, leading to a 3% stock price drop. On July 24, 2025, Dow Chemical Company reported a Q2 2025 non-GAAP loss per share of $0.42 and net sales of $10.1 billion, significantly missing analyst expectations. Following this, Dow Chemical Company's stock price fell by over 17%, and the company announced a dividend cut from $0.70 to $0.35 per share.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard